AC
ABBV icon

Addison Capital’s AbbVie ABBV Stock Holding History

Addison Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
4,867
-317
-6% -$70.3K 0.19% 96
2025
Q4 		$1.18M Sell
5,184
-1,110
-18% -$253K 0.3% 71
2025
Q3 		$1.46M Sell
6,294
-546
-8% -$111K 0.43% 59
2025
Q2 		$1.27M Buy
6,840
+245
+4% +$45.5K 0.44% 59
2025
Q1 		$1.38M Sell
6,595
-400
-6% -$77.8K 0.54% 53
2024
Q4 		$1.24M Sell
6,995
-197
-3% -$36.2K 0.49% 53
2024
Q3 		$1.42M Sell
7,192
-1,050
-13% -$196K 0.57% 43
2024
Q2 		$1.41M Sell
8,242
-81
-1% -$13.4K 0.61% 41
2024
Q1 		$1.52M Buy
8,323
+288
+4% +$49.6K 0.75% 38
2023
Q4 		$1.25M Buy
8,035
+742
+10% +$108K 0.77% 36
2023
Q3 		$1.09M Sell
7,293
-158
-2% -$23.2K 0.85% 34
2023
Q2 		$1M Sell
7,451
-222
-3% -$32.6K 0.72% 39
2023
Q1 		$1.22M Sell
7,673
-26
-0.3% -$3.98K 0.92% 33
2022
Q4 		$1.24M Hold
7,699
– – 0.78% 39
2022
Q3 		$1.03M Hold
7,699
– – 0.64% 48
2022
Q2 		$1.18M Sell
7,699
-451
-6% -$68.9K 0.69% 44
2022
Q1 		$1.32M Buy
8,150
+1,090
+15% +$158K 0.63% 49
2021
Q4 		$956K Sell
7,060
-74
-1% -$8.74K 0.43% 50
2021
Q3 		$770K Hold
7,134
– – 0.36% 57
2021
Q2 		$804K Buy
7,134
+959
+16% +$108K 0.39% 55
2021
Q1 		$668K Hold
6,175
– – 0.37% 56
2020
Q4 		$662K Sell
6,175
-12
-0.2% -$1.15K 0.4% 55
2020
Q3 		$542K Sell
6,187
-49
-0.8% -$4.61K 0.38% 54
2020
Q2 		$612K Buy
+6,236
New +$549K 0.47% 47
2015
Q3 		– Sell
-6,297
Closed -$423K – 86
2015
Q2 		$423K Buy
+6,297
New +$411K 0.39% 62

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Addison Capital's ABBV Position: Q1 2026 in Review

Addison Capital reduced its AbbVie (ABBV) stake by 6.1% in Q1 2026, selling an estimated $70.3K and leaving 4,867 shares worth $1.06M. The position accounts for 0.19% of the portfolio, ranked #96.

Addison Capital first reported a position in ABBV in Q2 2015 and has held it in 25 quarters since. The position peaked at $1.52M in Q1 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Addison Capital held 4,867 shares of AbbVie worth $1.06M as of Q1 2026.
  • Addison Capital sold 317 AbbVie shares in Q1 2026, an estimated $70.3K.
  • AbbVie made up 0.19% of Addison Capital's portfolio in Q1 2026, its #96 holding.
  • Addison Capital first reported a position in AbbVie in Q2 2015 and has held it in 25 quarters since.
  • Addison Capital's AbbVie position peaked at $1.52M in Q1 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Addison Capital's 13F filing for Q1 2026, filed 29 Apr 2026.